Anthelmintic compounds and compositions and method of using thereof

US10155725B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10155725-B2
Application numberUS-201514981847-A
CountryUS
Kind codeB2
Filing dateDec 28, 2015
Priority dateNov 20, 2012
Publication dateDec 18, 2018
Grant dateDec 18, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to novel anthelmintic compounds of formula (I) below: wherein Y and Z are independently a bicyclic carbocyclic or a bicyclic heterocyclic group, or one of Y or Z is a bicyclic carbocyclic or a bicyclic heterocyclic group and the other of Y or Z is alkyl, alkenyl, alkynyl, cycloalkyl, phenyl, heterocyclyl or heteroaryl, and variables X 1 , X 2 , X 3 , X 4 , X 5 , X 6 , X 7 and X 8 are as defined herein. The invention also provides for veterinary compositions comprising the anthelmintic compounds of the invention, and their uses for the treatment and prevention of parasitic infections in animals.

First claim

Opening claim text (preview).

What is claimed is: 1. An anthelmintic compound of formula (IA-2): wherein Y is a bicyclic carbocyclic or a bicyclic heterocyclic group selected from the group consisting of naphthyl, indolyl, benzothiazolyl, benzoxazolyl, benzodioxolyl, benzothienyl, quinuclidinyl, quinolinyl, tetrahydroisoquinolinyl, isoquinolinyl, benzimidazolyl, indolizinyl, benzofuranyl, dihydrobenzofuranyl, chromonyl, coumarinyl, benzopyranyl, cinnolinyl, quinoxalinyl, indazolyl, pyrrolopyridyl, furopyridinyl, dihydroisoindolyl, dihydroquinazolinyl and tetrahydroquinolinyl optionally substituted by one or more of halogen, nitro, cyano, hydroxy, hydroxyalkyl, amino, alkylamino, dialkylamino, aminoalkyl, alkyl, haloalkyl, alkoxy, haloalkoxy, alkylthio, SF 5 , haloalkylthio, alkylsulfinyl, haloalkylsulfinyl, alkyl sulfonyl or haloalkylsulfonyl; Z is phenyl optionally substituted with one or more halogen, nitro, cyano, or haloalkyl; X 1 is a bond, X 8 is —O—, or —NH—, which is optionally substituted with alkyl; Ring A is L1: W is O or S; R 2 and R 3 are independently hydrogen or alkyl; n is 1, 2 or 3; and r is 0 to 5. 2. A composition for the treatment of a parasitic infection or infestation in an animal, comprising an effective amount of at least one anthelmintic compound of claim 1 in combination with a pharmaceutically acceptable carrier. 3. The composition of claim 2 , wherein the composition comprises an additional parasiticidal active agent. 4. A method for the treatment of a parasitic infection or infestation in an animal, comprising administering an effective amount of the anthelmintic compound of claim 1 to the animal. 5. The compound of claim 1 , wherein X 8 is —O—, —NH— or —N(CH 3 )—. 6. The compound of claim 5 , wherein: R 2 and R 3 are independently hydrogen or C 1 -C 3 alkyl; and X 8 is —NH— or —N(CH 3 )—. 7. The compound of claim 6 , wherein Y is naphthyl, benzothiazolyl, benzoxazolyl, benzothienyl, quinolinyl, isoquinolinyl, indolizinyl, benzofuranyl or dihydrobenzofuranyl optionally substituted by one or more halogen, alkyl, haloalkyl, alkylthio, haloalkylthio, alkoxy, haloalkoxy, SF 5 , alkylsulfinyl, haloalkylsulfinyl, alkylsulfonyl or haloalkylsulfonyl; and Z is phenyl optionally substituted with one or more halogen, nitro, cyano or CF 3 . 8. The compound of claim 7 , wherein Y is naphthyl, benzothiazolyl, benzoxazolyl, quinolinyl, isoquinolinyl, indolizinyl, benzofuranyl or dihydrobenzofuranyl optionally substituted with one or more halogen, haloalkyl, haloalkylthio, SF 5 or haloalkoxy; and Z is phenyl substituted with one or more fluoro, nitro or CF 3 . 9. The compound of claim 7 , wherein Y is naphthyl, benzothiazolyl, benzoxazolyl, quinolinyl, isoquinolinyl, indolizinyl, benzofuranyl or dihydrobenzofuranyl optionally substituted with one or more halogen haloalkyl, haloalkoxy, SF 5 or haloalkylthio; and Z is phenyl substituted with one or more fluoro, cyano or CF 3 . 10. The compound of claim 8 , wherein Y is naphthyl, benzothiazolyl, benzoxazolyl, quinolinyl, isoquinolinyl, indolizinyl, benzofuranyl or dihydrobenzofuranyl optionally substituted with one or more halogen, CF 3 , —OCF 3 , —SCF 3 or SF 5 ; and Z is phenyl substituted with nitro and CF 3 . 11. The compound of claim 9 , wherein Y is naphthyl, benzothiazolyl, benzoxazolyl, quinolinyl, isoquinolinyl benzofuranyl or dihydrobenzofuranyl, optionally substituted with one or more halogen, CF 3 , —OCF 3 , —SCF 3 or —SF 5 ; and Z is phenyl substituted with cyano and CF 3 . 12. The compound of claim 8 , wherein: Y is naphthyl, quinolinyl, benzothiazolyl or benzoxazolyl optionally substituted with one or more halogen, or C 1 -C 3 haloalkyl; X 8 is —NH—; R 2 and R 3 are each independently hydrogen or C 1 -C 3 alkyl; Z is phenyl optionally substituted with one or more of F, nitro, cyano or CF 3 ; and n is 2 or 3. 13. The compound of claim 12 , wherein: Y is naphthyl optionally substituted with one or more F, Cl or CF 3 ; R 2 and R 3 are independently hydrogen or CH 3 ; Z is phenyl substituted with one or more nitro, cyano or CF 3 . 14. The compound of claim 12 , wherein: Y is quinolinyl optionally substituted with one or more F, Cl or CF 3 ; R 2 and R 3 are independently hydrogen or CH 3 ; Z is phenyl substituted with one or more nitro, cyano or CF 3 . 15. The compound of claim 12 , wherein: Y is benzothiazole optionally substituted with one or more F, Cl or CF 3 ; R 2 and R 3 are independently hydrogen or CH 3 ; Z is phenyl substituted with one or more nitro, cyano or CF 3 . 16. The compound of claim 12 , wherein: Y is benzoxazole optionally substituted with one or more F, Cl or CF 3 ; R 2 and R 3 are independently hydrogen or CH 3 ; Z is phenyl substituted with one or more nitro, cyano or CF 3 .

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10155725B2 cover?
The present invention relates to novel anthelmintic compounds of formula (I) below: wherein Y and Z are independently a bicyclic carbocyclic or a bicyclic heterocyclic group, or one of Y or Z is a bicyclic carbocyclic or a bicyclic heterocyclic group and the other of Y or Z is alkyl, alkenyl, alkynyl, cycloalkyl, phenyl, heterocyclyl or heteroaryl, and variab…
Who is the assignee on this patent?
Merial Inc
What technology area does this patent fall under?
Primary CPC classification C07D215/38. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).